Primer on the Autonomic Nervous System This
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Communication Center
2/16/2012 Communication Center Nervous System Regulation •The Neural System is only 3% of your body weight, but is the most complex organ system. •Nervous impulses are fast acting (milliseconds) Neural vs. Hormonal but short lived. Overview •The nervous system includes all neural tissue in the body. Basic units are: Two Anatomical Divisions of The Nervous System a. Neurons (individual nerve cells) 1. CNS: Central Nervous System b. Neuroglia • supporting cells • Brain & Spinal Cord • separate & protect the neurons • Responsible for integrating, processing, & • provide supporting framework coordinatinggy sensory data and motor commands. i.e.- stumble example • act as phagocytes • regulate composition of interstitial fluid • The brain is also the organ responsible for • a.k.a. glial cells intelligence, memory, learning, & emotion • outnumber neurons 1 2/16/2012 2. PNS: Peripheral Nervous System PNS has 2 functional divisions • All nervous tissue outside CNS Afferent Division (Sensory) • Carries sensory data to CNS, carries motor •Bring sensory information to CNS from receptors in commands from the CNS. peripheral nervous tissue & organs. • Bundles of nerve fibers carry impulses in the PNS are known as per ip hera l nerves or jus t “nerves”. Efferent Division (Motor) •Carries motor commands from CNS to muscles & • Nerves attached to the brain are called cranial glands, these target organs are called effectors. nerves. Nerves attached to the spinal cord are called spinal nerves. The Efferent Division is broken into Somatic & The ANS has a: Autonomic Components (SNS) Somatic System: controls skeletal muscle contractions these can be voluntary (conscious) or sympathetic division involuntary (unconscious) {reflexes}. } antagonistic effects parasympathetic (ANS) Au tonom ic Sys tem: * a.k.a. -
The Noradrenaline Transporter As Site of Action for the Anti-Parkinson Drug Amantadine
Neuropharmacology 62 (2012) 1708e1716 Contents lists available at SciVerse ScienceDirect Neuropharmacology journal homepage: www.elsevier.com/locate/neuropharm The noradrenaline transporter as site of action for the anti-Parkinson drug amantadine Christian Sommerauer a, Patrick Rebernik a, Harald Reither a, Christian Nanoff b, Christian Pifl a,* a Center for Brain Research, Medical University of Vienna, Spitalgasse 4, A-1090 Vienna, Austria b Center for Physiology and Pharmacology, Institute of Pharmacology, Medical University of Vienna, Wahringerstrasse 13a, A-1090 Vienna, Austria article info abstract Article history: Amantadine is an established antiparkinsonian drug with a still unclear molecular site of action. In vivo Received 5 September 2011 studies on rodents, in vitro studies on tissue of rodents as well as binding studies on post mortem human Received in revised form tissue implicate monoamine transporters and NMDA receptors. In order to re-examine its action at 17 November 2011 human variants of these proteins on intact cells we established cells stably expressing the human NR1/2A Accepted 28 November 2011 NMDA-receptor, noradrenaline transporter (NAT) or dopamine transporter (DAT) and tested the activity of amantadine in patch-clamp, uptake, release, and cytotoxicity experiments. Amantadine was less Keywords: potent in blockade of NMDA-induced inward currents than in blockade of noradrenaline uptake and in Amantadine Noradrenaline transporter induction of inward currents in NAT expressing cells. It was 30 times more potent in blocking uptake in e m Carrier-mediated release NAT- than in DAT cells. Amantadine induced NAT-mediated release at concentrations of 10 100 Min Transport-related currents superfusion experiments and blocked NAT-mediated cytotoxicity of the parkinsonism inducing neuro- þ NMDA-receptor toxin 1-methyl-4-phenyl-pyridinium (MPP ) at concentrations of 30e300 mM, whereas 300e1000 mM Parkinson’s disease amantadine was necessary to block NMDA-receptor mediated cytotoxicity. -
P2 Receptor-Mediated Modulation of Neurotransmitter Release—An Update
Purinergic Signalling (2007) 3:269–284 DOI 10.1007/s11302-007-9080-0 ORIGINAL ARTICLE P2 receptor-mediated modulation of neurotransmitter release—an update Beáta Sperlágh & Attila Heinrich & Cecilia Csölle Received: 13 July 2007 /Accepted: 28 August 2007 / Published online: 9 October 2007 # Springer Science + Business Media B.V. 2007 Abstract Presynaptic nerve terminals are equipped with a ENPP ectonucleotide pyrophosphatase number of presynaptic auto- and heteroreceptors, including EJP excitatory junction potential ionotropic P2X and metabotropic P2Y receptors. P2 recep- ENTPDase ectonucleoside triphosphate diphosphohydro- tors serve as modulation sites of transmitter release by ATP lase and other nucleotides released by neuronal activity and EPP end plate potential pathological signals. A wide variety of P2X and P2Y EPSC excitatory postsynaptic current receptors expressed at pre- and postsynaptic sites as well as EPSP excitatory postsynaptic potential in glial cells are involved directly or indirectly in the GABA +-aminobutyric acid modulation of neurotransmitter release. Nucleotides are GPCR G-protein coupled receptor released from synaptic and nonsynaptic sites throughout the IL-1β interleukin-1β nervous system and might reach concentrations high enough IPSC inhibitory postsynaptic current to activate these receptors. By providing a fine-tuning LC locus coeruleus mechanism these receptors also offer attractive sites for LPS lipopolysaccharide pharmacotherapy in nervous system diseases. Here we mEPP miniature EPP review the rapidly emerging data on the modulation of mEPSC miniature EPSC transmitter release by facilitatory and inhibitory P2 receptors NA noradrenaline and the receptor subtypes involved in these interactions. NMJ neuromuscular junction NT neurotransmitter Keywords Neuromodulation . Presynaptic . P2X receptor . NTS nucleus tractus solitarii P2Y receptors . -
Qt9vp7s85t.Pdf
UC Irvine UC Irvine Previously Published Works Title Modulation of anxiety through blockade of anandamide hydrolysis. Permalink https://escholarship.org/uc/item/9vp7s85t Journal Nature medicine, 9(1) ISSN 1078-8956 Authors Kathuria, Satish Gaetani, Silvana Fegley, Darren et al. Publication Date 2003 DOI 10.1038/nm803 License https://creativecommons.org/licenses/by/4.0/ 4.0 Peer reviewed eScholarship.org Powered by the California Digital Library University of California ARTICLES Modulation of anxiety through blockade of anandamide hydrolysis SATISH KATHURIA1, SILVANA GAETANI1, DARREN FEGLEY1, FERNANDO VALIÑO1, ANDREA DURANTI2, ANDREA TONTINI2, MARCO MOR3, GIORGIO TARZIA2, GIOVANNA LA RANA4, ANTONIO CALIGNANO4, ARCANGELA GIUSTINO5, MARIA TATTOLI5, MAURA PALMERY6, VINCENZO CUOMO6 & DANIELE PIOMELLI1 1Department of Pharmacology, University of California, Irvine, California, USA 2Institute of Medicinal Chemistry, University of Urbino, Urbino, Italy 3Pharmaceutical Department, University of Parma, Parma, Italy 4Department of Experimental Pharmacology, University of Naples, Naples, Italy 5Department of Pharmacology and Human Physiology, University of Bari, Bari, Italy 6Department of Pharmacology and General Physiology, University of Rome “La Sapienza”, Rome, Italy Correspondence should be addressed to D.P.; e-mail: [email protected] Published online 2 December 2002; doi:10.1038/nm803 The psychoactive constituent of cannabis, ∆9-tetrahydrocannabinol, produces in humans subjec- tive responses mediated by CB1 cannabinoid receptors, indicating that endogenous cannabi- noids may contribute to the control of emotion. But the variable effects of ∆9-tetrahydrocannabinol obscure the interpretation of these results and limit the therapeutic po- tential of direct cannabinoid agonists. An alternative approach may be to develop drugs that am- plify the effects of endogenous cannabinoids by preventing their inactivation. -
Properties of the Venous and Arterial Innervation in the Mesentery
J. Smooth Muscle Res. (2003) 39 (6): 269–279 269 Invited Review Properties of the Venous and Arterial Innervation in the Mesentery David L. KREULEN1 1Department of Physiology, Michigan State University, East Lansing, MI 48824-3320, USA Introduction The neural control of arteries and veins involves interactions between several vasoactive neurotransmitters released from the postganglionic sympathetic nerves and spinal sensory nerves. Sympathetic nerves are primarily vasoconstrictor in their action while the sensory nerves are vasodilatory; a result of the neurotransmitters released by these nerves. Thus, the nervous regulation of the vascular component of systemic blood pressure and of regional blood flow is the summation of vasoconstrictor and vasodilatory influences. Also, although the influence of arterial diameter on systemic blood pressure has received the most attention, venous diameter and compliance also are important in the regulation of blood pressure. The nervous regulation of blood flow and blood pressure depends upon the organization of sensory and sympathetic pathways to the vasculature as well as the events at the neuro-effector junctions in artery and vein. The sympathetic and sensory innervation of the mesenteric circulation consists of prevertebral sympathetic ganglion and dorsal root ganglion neurons, respectively. The axons of the neurons travel to the mesenteric arteries and veins in the paravascular nerves, which divide in the adventitia of the blood vessels to form the perivascular nerve plexus. Ultimately these axons divide into terminal axons, lose their Schwann cell sheath, and form neuroeffector junctions with vascular smooth muscle cells (Klemm et al., 1993). Although we know that arteries and veins are innervated by separate sympathetic neurons, all the mechanisms whereby these separate innervations regulate systemic blood pressure are not known. -
Neuron Types and Neurotransmitters
Neuron types and Neurotransmitters Faisal I. Mohammed. PhD, MD University of Jordan 1 Objectives Understand synaptic transmission List types of sensory neurons Classify neurotransmitters Explain the mechanism of neurotransmission Judge the types of receptors for the neurotrasmitters University of Jordan 2 Functional Unit (Neuron) 3 Transmission of Receptor Information to the Brain ➢The larger the nerve fiber diameter the faster the rate of transmission of the signal ➢Velocity of transmission can be as fast as 120 m/sec or as slow as 0.5 m/sec ➢Nerve fiber classification ➢type A - myelinated fibers of varying sizes, generally fast transmission speed ➢subdivided into a, b, g, d type B- partially myelinated neurons (3-14m/sec speed) ➢type C - unmyelinated fibers, small with slow transmission speed University of Jordan 4 Types of Nerve Fiber -Myelinated fibers – Type A (types I, II and III) - A α - A β - A γ - A δ -Umyelinated Fibers- Type C (type IV) University of Jordan 5 Neuron Classification University of Jordan 6 Structural Classification of Neurons University of Jordan 7 Neurotransmitters ❖Chemical substances that function as synaptic transmitters 1. Small molecules which act as rapidly acting transmitters ❖acetylcholine, norepinephrine, dopamine, serotonin, GABA, glycine, glutamate, NO 2. Neuropeptides (Neuromodulators) ❖more potent than small molecule transmitters, cause more prolonged actions ❖endorphins, enkephalins, VIP, ect. ❖hypothalamic releasing hormones ❖TRH, LHRH, ect. ❖pituitary peptides ❖ACTH, prolactin, vasopressin, -
Shifting Gears: Liver SR-BI Drives Reverse Cholesterol Transport in Macrophages
Shifting gears: liver SR-BI drives reverse cholesterol transport in macrophages Astrid E. van der Velde, Albert K. Groen J Clin Invest. 2005;115(10):2699-2701. https://doi.org/10.1172/JCI26241. Commentary Cholesterol efflux from macrophages, the first step in reverse cholesterol transport (RCT), is assumed to play a critical role in the pathogenesis of atherosclerosis. However, in vivo proof supporting this hypothesis is lacking, due to difficulties in determining the activity of this first step in RCT. In this issue of the JCI, Zhang et al. apply their recently developed method for measuring RCT in vivo to estimate RCT in mouse models with varying levels of HDL turnover. A surprisingly efficient clearance of cholesterol to feces is observed in mice overexpressing hepatic scavenger receptor class B type I (SR-BI), whereas in SR-BI–knockout mice, cholesterol clearance is diminished. The study demonstrates that hepatic SR- BI is a positive regulator of macrophage RCT in vivo. Find the latest version: https://jci.me/26241/pdf commentaries 1. Saitz, R. 2005. Clinical practice. Unhealthy alcohol 12. Willinger, U., et al. 2002. Anxiety as a predictor of 22. Valdez, G., and Koob, G. 2004. Allostasis and dys- use. N. Engl. J. Med. 352:596–607. relapse in detoxified alcohol-dependent patients. regulation of corticotropin-releasing factor and 2. Grant, B.F. 1994. Alcohol consumption, alcohol Alcohol Alcohol. 37:609–612. neuropeptide Y systems: implications for the devel- abuse and alcohol dependence. The United States 13. Pandey, S.C., Zhang, H., Roy, A., and Xu, T. 2005. opment of alcoholism. -
Modulation of NMDA Receptor Activity During Physiological and Pathophysiological Events Christine Marie Emnett Washington University in St
Washington University in St. Louis Washington University Open Scholarship Arts & Sciences Electronic Theses and Dissertations Arts & Sciences Winter 12-15-2014 Modulation of NMDA Receptor Activity During Physiological and Pathophysiological Events Christine Marie Emnett Washington University in St. Louis Follow this and additional works at: https://openscholarship.wustl.edu/art_sci_etds Part of the Biology Commons Recommended Citation Emnett, Christine Marie, "Modulation of NMDA Receptor Activity During Physiological and Pathophysiological Events" (2014). Arts & Sciences Electronic Theses and Dissertations. 347. https://openscholarship.wustl.edu/art_sci_etds/347 This Dissertation is brought to you for free and open access by the Arts & Sciences at Washington University Open Scholarship. It has been accepted for inclusion in Arts & Sciences Electronic Theses and Dissertations by an authorized administrator of Washington University Open Scholarship. For more information, please contact [email protected]. WASHINGTON UNIVERSITY IN ST. LOUIS Division of Biology and Biomedical Sciences Neurosciences Dissertation Examination Committee: Steven Mennerick, Chair James Huettner Daniel Kerschensteiner Peter D. Lukasiewicz Joseph Henry Steinbach Modulation of NMDA Receptor Activity During Physiological and Pathophysiological Events by Christine Marie Emnett A dissertation presented to the Graduate School of Arts and Sciences of Washington University in partial fulfillment of the requirements for the degree of Doctor of Philosophy December 2014 -
Identity of Endogenous NMDAR Glycine Site Agonist in Amygdala Is Determined by Synaptic Activity Level
ARTICLE Received 23 Jan 2013 | Accepted 21 Mar 2013 | Published 23 Apr 2013 DOI: 10.1038/ncomms2779 Identity of endogenous NMDAR glycine site agonist in amygdala is determined by synaptic activity level Yan Li 1, Silvia Sacchi2, Loredano Pollegioni2, Alo C. Basu1, Joseph T. Coyle1 & Vadim Y. Bolshakov1 Mechanisms of N-methyl-D-aspartate receptor-dependent synaptic plasticity contribute to the acquisition and retention of conditioned fear memory. However, synaptic rules which may determine the extent of N-methyl-D-aspartate receptor activation in the amygdala, a key structure implicated in fear learning, remain unknown. Here we show that the identity of the N-methyl-D-aspartate receptor glycine site agonist at synapses in the lateral nucleus of the amygdala may depend on the level of synaptic activation. Tonic activation of N-methyl- D-aspartate receptors at synapses in the amygdala under low activity conditions is supported by ambient D-serine, whereas glycine may be released from astrocytes in response to afferent impulses. The release of glycine may decode the increases in afferent activity levels into enhanced N-methyl-D-aspartate receptor-mediated synaptic events, serving an essential function in the induction of N-methyl-D-aspartate receptor-dependent long-term potentiation in fear conditioning pathways. 1 Department of Psychiatry, McLean Hospital, Harvard Medical School, Belmont, Massachusetts 02478, USA. 2 Department of Biotechnology and Molecular Sciences, University of Insubria, ‘The Protein Factory’ Research Center for Protein Biotechnologies, Politecnico di Milano and University of Insubria, Varese 21100, Italy. Correspondence and requests for materials should be addressed to V.Y.B. (email: [email protected]). -
Targeting Maladaptive Plasticity After Spinal Cord Injury to Prevent the Development of Autonomic Dysreflexia
University of Kentucky UKnowledge Theses and Dissertations--Physiology Physiology 2019 TARGETING MALADAPTIVE PLASTICITY AFTER SPINAL CORD INJURY TO PREVENT THE DEVELOPMENT OF AUTONOMIC DYSREFLEXIA Khalid C. Eldahan University of Kentucky, [email protected] Author ORCID Identifier: https://orcid.org/0000-0003-1674-2386 Digital Object Identifier: https://doi.org/10.13023/etd.2019.064 Right click to open a feedback form in a new tab to let us know how this document benefits ou.y Recommended Citation Eldahan, Khalid C., "TARGETING MALADAPTIVE PLASTICITY AFTER SPINAL CORD INJURY TO PREVENT THE DEVELOPMENT OF AUTONOMIC DYSREFLEXIA" (2019). Theses and Dissertations--Physiology. 41. https://uknowledge.uky.edu/physiology_etds/41 This Doctoral Dissertation is brought to you for free and open access by the Physiology at UKnowledge. It has been accepted for inclusion in Theses and Dissertations--Physiology by an authorized administrator of UKnowledge. For more information, please contact [email protected]. STUDENT AGREEMENT: I represent that my thesis or dissertation and abstract are my original work. Proper attribution has been given to all outside sources. I understand that I am solely responsible for obtaining any needed copyright permissions. I have obtained needed written permission statement(s) from the owner(s) of each third-party copyrighted matter to be included in my work, allowing electronic distribution (if such use is not permitted by the fair use doctrine) which will be submitted to UKnowledge as Additional File. I hereby grant to The University of Kentucky and its agents the irrevocable, non-exclusive, and royalty-free license to archive and make accessible my work in whole or in part in all forms of media, now or hereafter known. -
The Role of Norepinephrine in the Pharmacology of 3,4
!"#$%&'#$&($)&*#+,-#+"*,-#$,-$."#$/"0*102&'&34$&($ 56789#."4'#-#:,&;41#."01+"#.01,-#$<9=9>6$?#[email protected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`,E#-E$ I0--$ D-.#*$ 2*#0.,J#2&11&-@X&*3a',2#-2#@aY48-28 -:aSX]a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
The Intrinsic Cardiac Nervous System and Its Role in Cardiac Pacemaking and Conduction
Journal of Cardiovascular Development and Disease Review The Intrinsic Cardiac Nervous System and Its Role in Cardiac Pacemaking and Conduction Laura Fedele * and Thomas Brand * Developmental Dynamics, National Heart and Lung Institute (NHLI), Imperial College, London W12 0NN, UK * Correspondence: [email protected] (L.F.); [email protected] (T.B.); Tel.: +44-(0)-207-594-6531 (L.F.); +44-(0)-207-594-8744 (T.B.) Received: 17 August 2020; Accepted: 20 November 2020; Published: 24 November 2020 Abstract: The cardiac autonomic nervous system (CANS) plays a key role for the regulation of cardiac activity with its dysregulation being involved in various heart diseases, such as cardiac arrhythmias. The CANS comprises the extrinsic and intrinsic innervation of the heart. The intrinsic cardiac nervous system (ICNS) includes the network of the intracardiac ganglia and interconnecting neurons. The cardiac ganglia contribute to the tight modulation of cardiac electrophysiology, working as a local hub integrating the inputs of the extrinsic innervation and the ICNS. A better understanding of the role of the ICNS for the modulation of the cardiac conduction system will be crucial for targeted therapies of various arrhythmias. We describe the embryonic development, anatomy, and physiology of the ICNS. By correlating the topography of the intracardiac neurons with what is known regarding their biophysical and neurochemical properties, we outline their physiological role in the control of pacemaker activity of the sinoatrial and atrioventricular nodes. We conclude by highlighting cardiac disorders with a putative involvement of the ICNS and outline open questions that need to be addressed in order to better understand the physiology and pathophysiology of the ICNS.